JP2012522522A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522522A5
JP2012522522A5 JP2012503839A JP2012503839A JP2012522522A5 JP 2012522522 A5 JP2012522522 A5 JP 2012522522A5 JP 2012503839 A JP2012503839 A JP 2012503839A JP 2012503839 A JP2012503839 A JP 2012503839A JP 2012522522 A5 JP2012522522 A5 JP 2012522522A5
Authority
JP
Japan
Prior art keywords
stec
fusion protein
epitope fusion
composition
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012503839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/000516 external-priority patent/WO2010115278A1/en
Publication of JP2012522522A publication Critical patent/JP2012522522A/ja
Publication of JP2012522522A5 publication Critical patent/JP2012522522A5/ja
Pending legal-status Critical Current

Links

JP2012503839A 2009-04-06 2010-04-06 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物 Pending JP2012522522A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21198909P 2009-04-06 2009-04-06
US61/211,989 2009-04-06
US21660809P 2009-05-19 2009-05-19
US61/216,608 2009-05-19
PCT/CA2010/000516 WO2010115278A1 (en) 2009-04-06 2010-04-06 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015172551A Division JP2016029049A (ja) 2009-04-06 2015-09-02 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物

Publications (2)

Publication Number Publication Date
JP2012522522A JP2012522522A (ja) 2012-09-27
JP2012522522A5 true JP2012522522A5 (enExample) 2013-05-23

Family

ID=42935602

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012503839A Pending JP2012522522A (ja) 2009-04-06 2010-04-06 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物
JP2015172551A Pending JP2016029049A (ja) 2009-04-06 2015-09-02 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015172551A Pending JP2016029049A (ja) 2009-04-06 2015-09-02 志賀毒素産生大腸菌感染を処置及び予防するための方法並びに組成物

Country Status (7)

Country Link
US (1) US8734811B2 (enExample)
EP (1) EP2417165B1 (enExample)
JP (2) JP2012522522A (enExample)
AU (1) AU2010234193B2 (enExample)
BR (1) BRPI1014505B1 (enExample)
CA (1) CA2757828C (enExample)
WO (1) WO2010115278A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2014001126A1 (es) * 2014-04-29 2014-08-29 Univ Chile Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
KR20220007619A (ko) * 2019-05-01 2022-01-18 이네이트 바이올로직스 엘엘씨 면역조절 조성물 및 방법
EP4054655A4 (en) * 2019-11-08 2024-02-28 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION
US20210369836A1 (en) * 2020-05-26 2021-12-02 Synlogic Operating Company, Inc. Surface display of proteins on recombinant bacteria and uses thereof
WO2024064200A2 (en) * 2022-09-20 2024-03-28 The Texas A&M University System Darpin-containing compositions and methods thereof
AR132724A1 (es) 2024-05-17 2025-07-23 Instituto Nac De Tecnologia Agropecuaria Inta Construcción de adn que codifica una proteína de fusión con al menos dos antígenos de escherichia coli enterohemorrágica, vectores, proteína de fusión, métodos de inmunización y vacunas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055400A (en) 1986-11-26 1991-10-08 University Of Guelph Leukotoxin gene of pasteurella haemolytica
US4957739A (en) 1987-08-13 1990-09-18 Board Of Regents, The University Of Texas System Pharmaceutical compositions of a 105 kD P. Haemolytica derived antigen useful for treatment of Shipping Fever
CA2014033C (en) 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
ES2108693T3 (es) * 1990-04-05 1998-01-01 Univ Saskatchewan Compuestos y tratamientos para la neumonia en animales.
US5273889A (en) 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5238823A (en) 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
AU2699192A (en) 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5723129A (en) 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5422110A (en) 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US6797272B1 (en) 1991-10-16 2004-09-28 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ES2389625T3 (es) 1996-04-23 2012-10-29 The University Of British Columbia Vacuna que comprende la proteína EspA asociada a Escherichia coli patógena
EP1029054B1 (en) 1997-11-12 2009-08-05 The University Of British Columbia Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
EP1098661A2 (en) * 1998-06-04 2001-05-16 Metamorphix, Inc. Gnrh vaccines for suppressing reproductive behavior in animals
US6365723B1 (en) 1998-12-04 2002-04-02 Wisconsin Alumni Research Foundation Sequences of E. coli O157
MXPA03006042A (es) * 2001-01-04 2005-02-14 Univ British Columbia Vacuna de escherichia colienterohemorragica.
AU2002347314A1 (en) * 2002-11-29 2004-06-23 Imperial College Innovations Limited Vaccine against enteropathogenic and enterohaemorragic escherichia coli
WO2007101337A1 (en) * 2006-03-06 2007-09-13 Bioniche Life Sciences Inc. Methods and compositions comprising bacterial type hi secreted proteins for mucosal immunization of animals
EP2420246A1 (en) * 2006-04-20 2012-02-22 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Methods and compositions based on shiga toxin type 1 protein

Similar Documents

Publication Publication Date Title
CN104007261B (zh) 禽三种呼吸道疾病三联快速检测试剂盒及应用
JP2012522522A5 (enExample)
JP2012515551A5 (enExample)
CN105906714A (zh) 一种布鲁氏菌病特异性融合蛋白抗原的制备及应用
WO2009099204A1 (ja) アビバクテリウム・パラガリナラム抗体の検出方法およびキット
CN105112375A (zh) 杂交瘤细胞株zjed0-02、抗埃博拉病毒gp蛋白单克隆抗体及其制备和应用
CN100494352C (zh) 检测牛结核抗体的免疫胶体金试纸条及制备方法
CN105198987A (zh) 一种抗化脓隐秘杆菌plo蛋白单克隆抗体及其识别的抗原表位和应用
CN104744572B (zh) 禽和猪戊型肝炎病毒共有抗原、单克隆抗体和制备方法及应用
CN105319359A (zh) 人肺炎链球菌量子点免疫层析检测卡及其制备方法和应用
CN105242043A (zh) 一种鉴别诊断口蹄疫病毒感染的多物种通用elisa试剂盒
Wu et al. A candidate competitive ELISA based on monoclonal antibody 3A8 for diagnosis of contagious bovine pleuropneumonia
CN101692089A (zh) 一种检测牛型结核分枝杆菌抗体的免疫层析试纸及其制备方法
JP2005535287A5 (enExample)
CN119350496A (zh) 洋葱伯克霍尔德菌群检测的抗体、免疫检测方法及应用
CN104678097B (zh) 一种用于肺结核诊断的结核分枝杆菌组合抗原
CN102707054B (zh) 大肠埃希氏菌OmpT抗体间接ELISA检测方法
Serroni et al. Expression of deleted, atoxic atypical recombinant beta2 toxin in a baculovirus system and production of polyclonal and monoclonal antibodies
CN105785037A (zh) 猪圆环病毒2型抗体快速检测层析试纸条及制备方法
Ji et al. Screening and Identification of B-Cell Epitopes in the P61 Protein of Nocardia brasiliensis
CN104610437A (zh) 包含禽戊型肝炎病毒orf3蛋白抗原区的重组蛋白及其制备和应用
CN105277694B (zh) 人a群链球菌量子点免疫层析检测卡及其制备方法和应用
CN110540599A (zh) 基于肺炎克雷伯菌表面蛋白抗体的肺炎克雷伯菌Elisa检测试剂盒及制备方法
CN116333063B (zh) 胸膜肺炎放线杆菌的三个候选抗原及其应用
CN105273082A (zh) 一种gfp多克隆抗体的制备方法